MENU
UPB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Upstream Bio (UPB) Ownership - Who owns Upstream Bio?
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
621.86M
P/E Ratio
N/A
Total Cash
431.38M
Projected Growth
N/A
Total Debt
1.7M
Revenue
2.3M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.02
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
UPB
Capitalization
622M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
431M
Total Cash/Share
8.02
Total Debt
1.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
2.3M
ROE
N/A
Book Value
446M
P/B Ratio
1.40
Cash Flow
N/A
Earnings
-1.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
53K
Current Ratio
47.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-94.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.65
Shares Held By Institutions
379M
Shares Outstanding - Current
53.8M
Total Liabilities
10.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-29.684
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information